Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy With Viaskin® Peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2016.12.901
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Elsevier BV